Scientists at the University of Southern California monitored 48 people with alcohol use disorder, which can leave people with the inability to control their drinking despite negative consequences.

The popularity of Ozempic and other GLP-1 receptor agonists could increase the chances of broad adoption of these treatments for alcohol use disorder. For the trial, researchers recruited 48 ...

The trial involved 48 people with alcohol-use disorder, which reflects a pattern of disruptive drinking and included heavy drinkers, which for men means consuming more than 14 drinks a week ...

This week, JAMA Psychiatry published the results of a small but significant trial that showed a similar effect on alcohol cravings. For two months, 48 people with alcohol use disorder were given ...

About 40% of participants who took the drug semaglutide in a nine-week study—which involved 48 adults with alcohol use disorder—reported no days drinking five or more alcoholic drinks ...

The study, conducted by researchers at the University of Southern California, involved 48 adults with alcohol use disorders. Participants received weekly injections of semaglutide or a placebo for ...

It happened Saturday around 4:30 p.m. on Highway 48, according to Minnesota State ... line and collided with the driver of a Ford F150. Alcohol is believed to have been a factor in the crash ...

Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...

(HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in alcohol use disorder (AUD), according to a study published online Feb. 12 in JAMA Psychiatry.